Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Ariana Resources (AAU) by Hot Stock Rockets in ShareProphets
- Avoid Ten Lifestyle Group (TENG) by Steve Moore in ShareProphets
- Avoid Biome Technologies (BIOM) by Steve Moore in ShareProphets
- Buy Aviva (AV.) by Harvey Jones in The Motley Fool
- Buy CMC Markets (CMCX) by Harvey Jones in The Motley Fool
- Buy ITV (ITV) by Simon Watkins in The Motley Fool
- Buy Legal & General Group (LGEN) by Simon Watkins in The Motley Fool
- Hold Vodafone Group (VOD) by DZ Bank
- Buy Premier Foods (PFD) by Jefferies
- Buy Intermediate Capital Group (ICG) by Deutsche Bank
- Overweight WH Smith (SMWH) by JP Morgan
- Outperform TT Electronics (TTG) by RBC Capital
- Buy International Consolidated Airlines Group SA (CDI) (IAG) by Goldman Sachs
- Neutral Dr. Martens (DOCS) by Goldman Sachs
- Buy Intermediate Capital Group (ICG) by Goldman Sachs
- Neutral Vistry Group (VTY) by JP Morgan
- Buy Babcock International Group (BAB) by Jefferies
- Buy Convatec Group (CTEC) by Jefferies
- Buy Altona Rare Earths (REE) by Hot Stock Rockets in ShareProphets
- Avoid Marks Electrical Group (MRK) by Steve Moore in ShareProphets
Physiomics (PYC) Share Price
Health Care Sector
NOTE: This is based on 17 open tips for Physiomics (PYC)
| Latest Bid : 0.65p | Latest Ask : 0.75p |
| High Today : 0.70p | Low Today : 0.65p |
| This Years High : 2.00p | This Years Low : 0.62p |
| Volume : 150,000 | MKT Cap : £1.38M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000
Physiomics (PYC) Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.Physiomics (PYC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-09-27 09:25:00 27/09/2024 | -12.50% |
| Avoid | Steve Moore | Premium Only | 2024-07-03 12:05:00 03/07/2024 | -12.50% |
| Avoid | Steve Moore | Premium Only | 2024-05-03 14:25:00 03/05/2024 | 43.75% |
| Sell | Tom Winnifrith | Premium Only | 2024-03-07 16:20:00 07/03/2024 | 48.08% |
| Avoid | Steve Moore | Premium Only | 2023-11-10 13:55:00 10/11/2023 | 55.00% |
Physiomics (PYC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.65p | Latest Ask : 0.75p |
| High Today : 0.70p | Low Today : 0.65p |
| This Years High : 2.00p | This Years Low : 0.62p |
| Volume : 150,000 | MKT Cap : £1.38M |
Physiomics Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Physiomics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-09-27 09:25:00 27/09/2024 | -12.50% |
| Avoid | Steve Moore | Premium Only | 2024-07-03 12:05:00 03/07/2024 | -12.50% |
| Avoid | Steve Moore | Premium Only | 2024-05-03 14:25:00 03/05/2024 | 43.75% |
| Sell | Tom Winnifrith | Premium Only | 2024-03-07 16:20:00 07/03/2024 | 48.08% |
| Avoid | Steve Moore | Premium Only | 2023-11-10 13:55:00 10/11/2023 | 55.00% |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000